Skip to main content

Pharmacokinetic and Pharmacodynamical Models

  • Chapter
  • First Online:
Optimal Impulsive Control for Cancer Therapy

Abstract

This chapter presents the Pharmacokinetic (PK) and Pharmacodynamical (PD) models. Concerning PK models, empirical and mechanistic models are explained, including their advantages and disadvantages. Compartmental models are described, including a discussion on their properties: positivity, mass conservation and stability. For PD models, such as for the PK models, empirical models and mechanistic models are referred as well. The mechanistic model described by the Hill equation is studied for different drugs and configurations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bastin G, Guffens V (2006) Congestion control in compartment network systems. Elsevier, Syst Control Lett 55:689–696

    Google Scholar 

  • Brunton LL, Lazo JS, Parker KL (2006) The pharmacological basis of therapeutics, 11th edn. MC Graw Hill, New York

    Google Scholar 

  • Chellaboina V, Bhat SP, Haddad WM, Bernstein DS (2009) Modeling and analysis of mass-action kinetics. IEEE Control Syst 29:60–78

    Google Scholar 

  • Farina L, Rinaldi S (2000) Positive linear systems—theory and applications. Wiley, New York

    Book  Google Scholar 

  • Goutelle S, Maurin M, Rougier F, Barbaut X, Bourguignon L, Ducher M, Maire P (2008) The Hill equation: a review of its capabilities in pharmacological modelling. Fund Clin Pharmacol 22(6):633–48

    Google Scholar 

  • Grognard F, Jadot F, Magni L, Bastin G, Sepulchre R, Wertz V (2001) Robust stabilization of a nonlinear cement mill model. IEEE Trans Autom Control 46(4):618–623

    Google Scholar 

  • Hacker M, Messer WS, II, Bachmann KA (2009) Pharmacology principles and practice. Elsevier, Amsterdam. ISBN:978-0-12-36921-5

    Google Scholar 

  • Haddad WM, Chellaboina V, Huii Q (2010) Nonnegative and compartmental dynamical systems. Princeton University Press, Princeton

    Book  Google Scholar 

  • Imsland L, Foss BA, Eikrem GO (2003) State feedback control of class of positive systems: application to gas-lift stabilization. In: European Control Conference, Cambridge, UK, pp 2499–2504

    Google Scholar 

  • Peng H, Cheung B (2009) A review on pharmacokinetic modeling and the effects of environmental stressors on pharmacokinetics for operational medicine: operational pharmacokinetics. Technical Report, Defense Research and Development Canada

    Google Scholar 

  • Pilari S (2011) Novel approaches to mechanistic pharmacokinetic/pharmacodynamic modeling. Ph.D. thesis, Freien Universitat, Berlin

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to João P. Belfo .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Belfo, J.P., Lemos, J.M. (2021). Pharmacokinetic and Pharmacodynamical Models. In: Optimal Impulsive Control for Cancer Therapy. SpringerBriefs in Electrical and Computer Engineering(). Springer, Cham. https://doi.org/10.1007/978-3-030-50488-5_2

Download citation

Publish with us

Policies and ethics